How Big is the Type 2 Diabetes Market | Industry Trends & Emerging Developments 2025

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA9511

Publication Date: Sep 2025

What is the size of the Type 2 Diabetes Market?

According to 6Wresearch internal database and industry insights, the Global Type 2 Diabetes Market was valued at USD 61.3 Billion in 2024 and is expected to reach USD 101.6 Billion by 2031, growing at a compound annual growth rate of 12.80% during the forecast period (2025-2031).

There are numbers of factors which are contributing in the expansion of the market include the rising prevalence of type 2 diabetes due to lifestyle changes, increasing awareness regarding diabetes management, and the growing demand for advanced treatment options such as insulin and oral medications.

View Main Report

Schedule Analyst Call

Key Growth Drivers of the Type 2 Diabetes Market

Diabetes rates are rising as a result of sedentary lifestyles and the prevalence of obesity.
Growing use of cutting-edge therapeutic techniques, such as insulin therapy and oral drugs
Increasing knowledge of and attention to type 2 diabetes early detection and treatment
Growing funding for the study and creation of novel medications and treatments
Improvements in insulin delivery systems and glucose monitoring technology

Type 2 Diabetes Market Trends

The Type 2 Diabetes Market is set to grow, driven by the increasing adoption of continuous glucose monitoring systems and insulin pumps. Another noteworthy trend is the growing emphasis on individualized diabetes care through the use of digital health tools like telemedicine and smartphone apps. The treatment landscape is changing as a result of the development of non-insulin drugs like SGLT-2 inhibitors and GLP-1 receptor agonists. Furthermore, the market is seeing an increase in the emphasis on preventive strategies to lower the risk of type 2 diabetes, such as lifestyle changes and weight management programs.

Emerging Developments in the Type 2 Diabetes Market

The Type 2 Diabetes Market is evolving with the increasing incorporation of digital health tools, including artificial intelligence powered diabetes management platforms and wearable devices for real-time glucose monitoring. Gene therapy and stem cell therapy research is accelerating, and future advances could lead to more long-lasting treatments. Pharmaceutical companies are also increasingly concentrating on combination therapies in an effort to lower treatment costs and enhance patient outcomes. Collaborations between medical device companies and pharmaceutical firms are resulting in innovative insulin delivery solutions.